.svg)
SHBG, the protein that decides how much sex hormone you can actually use
Sex Hormone Binding Globulin (SHBG) is a carrier protein made by the liver that binds and transports sex hormones in the blood. It has a strong attraction for testosterone and dihydrotestosterone, and a moderate one for estradiol (sex steroids; hepatocyte-derived high-affinity glycoprotein). An SHBG blood test measures how much of this carrier is present in circulation.
SHBG acts as the traffic controller for sex hormones. By binding them tightly, it limits how much is immediately available to enter cells and act on tissues (free and bioavailable fractions). Most hormone bound to SHBG is held in reserve, while the unbound portion is the readily active pool. Measuring SHBG therefore helps show how hormones are partitioned between bound and usable forms and provides essential context for total testosterone or estrogen results (hormone bioavailability, sex steroid homeostasis). In short, SHBG reflects the body’s regulation of hormone delivery—stabilizing transport, buffering sudden swings, and shaping the intensity of androgen and estrogen signaling.
Why an SHBG number changes the meaning of your testosterone or estradiol result
Sex Hormone Binding Globulin (SHBG) is a liver-made carrier protein that binds testosterone and estradiol, controlling how much is “free” to act on brain, muscle, skin, bone, metabolism, and reproductive tissues. It’s a master dial for hormone availability, so it helps explain symptoms even when total hormone levels look normal.
Big picture: SHBG links the liver, thyroid status, insulin signaling, and nutrition to sex-hormone action. Interpreting it alongside total and free testosterone or estradiol clarifies causes of symptoms, flags metabolic or bone risks, and frames long-term health trajectories.
Low, mid-range, and high SHBG — what each pattern points to
Reference ranges are age- and sex-specific: men usually run lower than women, children are higher before puberty, and pregnancy is much higher. For most adults, values near the middle of the lab range align with balanced free hormone levels; drifting to either extreme skews tissue exposure.
When SHBG is low, more hormone is unbound and bioactive. Physiologically this often reflects insulin resistance, higher visceral fat, fatty liver, hypothyroidism, or androgen excess. Women may notice acne, oily skin, scalp hair thinning, hirsutism, irregular cycles, or features of polycystic ovary syndrome. Men may have normal free testosterone despite low total levels, yet carry higher cardiometabolic risk. In teens, obesity-related insulin resistance commonly suppresses SHBG.
When SHBG is high, fewer hormones are free. This pattern appears with hyperthyroidism, liver conditions, aging, estrogen exposure, and pregnancy (a normal rise). Men can feel low libido, reduced strength, fatigue, or low mood from low free testosterone. Women may have lighter or irregular periods, vaginal dryness, low libido, and increased bone loss risk from lower free estradiol and androgens.
Caveats: what shifts SHBG independently of your hormones
Notes: Interpret SHBG alongside total testosterone or estradiol and albumin; calculated “free” values depend on SHBG and the formula used. Age, sex, pregnancy, thyroid status, liver health, insulin resistance, and medications (estrogens, androgens) materially shift SHBG, and assay methods vary by lab.
How SHBG fits into a broader hormonal read-out
Sex Hormone Binding Globulin (SHBG) is a liver-made transport protein that binds testosterone and estradiol and controls how much is “free” and active at tissues. Because free sex steroids influence energy, body composition, cardiovascular and bone health, fertility, and mood, SHBG functions as a systems signal integrating liver, thyroid, and insulin pathways with reproductive physiology.
Low values usually reflect reduced hepatic production or suppression by androgens and insulin—plainly, too much insulin, too many androgens, or too little thyroid hormone. This increases free androgens. In men, total testosterone may read low but bioavailable testosterone can be relatively preserved; low SHBG is also linked to insulin resistance and fatty liver. In women, lower SHBG often means higher free androgens with acne, hirsutism, and ovulatory disruption, patterns seen in polycystic ovary physiology.
Being in range suggests balanced transport with appropriate buffering of sex steroids, yielding steady reproductive signaling, bone turnover, and metabolic stability. For most adults, values in the mid-range for age and sex align with consistent hormone availability, though “within reference ranges” shifts with life stage.
High values usually reflect increased hepatic synthesis driven by estrogens or thyroid hormone, or lower androgen tone. This lowers free testosterone (and to a lesser extent free estradiol). In men, high SHBG can produce symptoms of androgen deficiency despite normal total testosterone. In women, it rises in pregnancy and with estrogen exposure, often reducing free androgens; hyperthyroidism and some chronic liver conditions can also elevate SHBG.
FAQs
It measures the concentration of SHBG in your blood to show how much testosterone and estradiol are bioavailable versus bound.
It explains symptoms despite “normal” totals, clarifies androgen or estrogen balance, and adds context to related markers.
Recheck when weight, training, thyroid status, or hormone therapy changes. Periodic testing helps track long-term trends.
Age, thyroid or liver function, insulin resistance, pregnancy, body composition, and estrogen/androgen exposure.
Usually no fasting is required, though paired tests (like insulin or lipids) may require it.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Selby, C. (1990). Sex hormone binding globulin: Origin, function and clinical significance. Annals of Clinical Biochemistry, 27(6), 532-541. https://doi.org/10.1177/000456329002700603
- Sá, E. Q., Sá, F. C., Oliveira, K. C., Feres, F., & Verreschi, I. T. (2014). Association between sex hormone-binding globulin (SHBG) and metabolic syndrome among men. São Paulo Medical Journal, 132(2), 111-115. https://doi.org/10.1590/1516-3180.2014.1322666
- Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024). Polycystic ovary syndrome. Nature Reviews Disease Primers, 10(1), 27. https://doi.org/10.1038/s41572-024-00511-3
- Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
- Gasbarrino, K., Daly, E., & Daskalopoulou, S. S. (2022). An LC-MS/MS methodological framework for steroid hormone measurement from human serum. Hormone and Metabolic Research, 54(5), 300-307. https://doi.org/10.1055/a-1768-0709
.avif)
.svg)
.svg)
